stockrowDr. Reddy's Laboratories Ltd (RDY) vs United Therapeutics Corporation (UTHR)
- Dr. Reddy's Laboratories Ltd RDY 14.53 −1.62%
- United Therapeutics Corporation UTHR 564.88 −7.17%
Dr. Reddy's Laboratories Ltd and United Therapeutics Corporation are both Drug Manufacturers Specialty & Generic companies. United Therapeutics Corporation is the larger, with a market value of $24.3B against $12.1B — 2.0× the size. United Therapeutics Corporation trades at the lower P/E: 19.7× against 44.4×. United Therapeutics Corporation grew revenue faster over the last twelve months: 1.89% against −15.5%. United Therapeutics Corporation has the higher net margin (38.6% vs 8.06%) and the higher return on invested capital (30.1% vs 4.77%). Across the 22 metrics below, United Therapeutics Corporation leads on 19 and Dr. Reddy's Laboratories Ltd on 3.
Valuation
Profitability
| Metric | RDY | UTHR | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 49.16% | 86.34% | 53.51% |
| Operating margin | 9.20% | 41.45% | 0.00% |
| Net margin | 8.06% | 38.61% | (2.45%) |
| Free cash flow margin | 2.88% | 27.21% | 0.00% |
| Return on equity | 6.60% | 19.13% | (0.80%) |
| Return on assets | 4.44% | 17.11% | (1.67%) |
| Return on invested capital | 4.77% | 30.13% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack